Anthropic Jumped 17% in Its Debut. Here’s Why I’m Waiting to Buy ANT Stock.

Resumen detallado
Anthropic's hot debut on the market tells me everything I need to know.
Anthropic's (ANT +17.07%) IPO was one of the most successful in history, with the stock spiking to $111.50 after the IPO price was set at $83 per share. However, the stock settled down immediately after that and ended the day at $97.17 per share, up 17%. That's a large gain on day one, and investors may be a bit wary about investing in a stock that rose that much in one day.
I'm in the same boat and am staying patient by not buying Anthropic shares yet. Why? I've got two important reasons that investors should keep in mind.
First, I don't know enough about Anthropic's business and how its management team does earnings reports. That could shift my sentiment one way or another, and I won't know anything about that for a few quarters. So, it could be six months or more before I'm comfortable with how Anthropic does its earnings releases.
On another earnings note, I want to see how Anthropic's revenue growth is trending. There's no debate about how fast Anthropic is growing, as revenue is increasing at a lightning pace. However, it is slowing down.
During Q3, its revenue totaled $17 billion, up more than 12-fold year over year. In Q2, its revenue totaled $11.6 billion and $4.7 billion in Q1. When you calculate the quarter-over-quarter growth rates, it reveals something interesting. In Q1, Anthropic's quarter-over-quarter growth rate was 132%. In Q2, that figure accelerated to 144%. In Q3, that total fell off a cliff to 47%.
That may seem like a reason to panic, and looking at the actual dollar figures provides more color. From Q1 to Q2, Anthropic added $6.82 billion in revenue. From Q2 to Q3, it added $5.41 billion. So, even from a raw revenue standpoint, Anthropic's Q3 was not nearly as successful as its Q2.
The question is: will that trend continue in Q4, or will there be a great jump in Q4 due to pent-up demand that maybe wasn't met in Q3?
I have no idea how to answer this question, which is why I think that staying patient here makes a lot of sense.
History is also on my…
Inicio del artículo, extracto de The Motley Fool. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)




